Video
Gregory Leighton, RPh, vice president of clinical solutions and patient access for Asembia, discusses how patient support services and hub providers can be used to focus on an individual’s needs and lifestyle for improving medication adherence.
Gregory Leighton, RPh, vice president of clinical solutions and patient access for Asembia, discusses how patient support services and hub providers can be used to focus on an individual’s needs and lifestyle for improving medication adherence.
Gregory Leighton, RPh: So, overall, when you think about improving patient outcomes, it’s how seamless can you make this process, and how educated is that patient on understanding what they need to do when they've received this product. So, anything that's geared towards improving costs, so that the patient can afford the medication, removing the barriers so they get the medication, and having some type of follow-up interaction mechanism at the patients convenience, is where the model needs to go.
When you look at patient support services and hub providers, something like a company like us, Asembia—what we really focus on is: how do you address all of those different touch points for those patients? Building a model that's unique and custom—not just to the product, but also taking that product and focusing on ‘how does it impact the patient's life’—is very critical to do that. So, when you when the patient gets the drug, when they can afford the drug, access improves overall. Then it's more streamlined. Once you have a good positive experience upstream, it's very easy to tie in an initiative or a compliance initiative afterwards, in order to make sure that the patient gets the best value.
FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a